Immunolocalization and messenger RNA expression of bone morphogenetic protein-6 in human benign and malignant prostatic tissue
about
Control of prostate cell growth: BMP antagonizes androgen mitogenic activity with incorporation of MAPK signals in Smad1The role of the BMP signaling antagonist noggin in the development of prostate cancer osteolytic bone metastasisConstitutive activation of BMP signalling abrogates experimental metastasis of OVCA429 cells via reduced cell adhesionBone morphogenic protein 6: a member of a novel class of prognostic factors expressed by normal and malignant plasma cells inhibiting proliferation and angiogenesis.The Yin and Yang of bone morphogenetic proteins in cancer.Nucleoporin 62-like protein activates canonical Wnt signaling through facilitating the nuclear import of β-catenin in zebrafish.Prostate cancer induces bone metastasis through Wnt-induced bone morphogenetic protein-dependent and independent mechanisms.VE-cadherin facilitates BMP-induced endothelial cell permeability and signalingSoluble ErbB3 levels in bone marrow and plasma of men with prostate cancerProstate cancer: the need for biomarkers and new therapeutic targets.Prostate cancer bone metastases acquire resistance to androgen deprivation via WNT5A-mediated BMP-6 induction.Emerging roles of the bone morphogenetic protein pathway in cancer: potential therapeutic target for kinase inhibition.Hypermethylation leads to bone morphogenetic protein 6 downregulation in hepatocellular carcinomaProstate cancer cells and bone stromal cells mutually interact with each other through bone morphogenetic protein-mediated signals.Bone morphogenetic protein 6 in skeletal metastases from prostate cancer and other common human malignancies.Bone morphogenetic protein signaling: implications in urology.Stromal TGF-β signaling induces AR activation in prostate cancer.
P2860
Q24337748-516DDADC-7A4A-4396-AB79-44C878069C72Q27437809-3E57486E-7EC9-4F89-AFEC-948DBCABA6FBQ33729002-5723882A-16C2-4224-9983-CE0E10590B38Q33748979-65DD1A7F-5222-4A06-970D-9DA5B525DD30Q34127207-EDE22EC4-B488-43EA-90D5-68AAD448EA28Q35165165-8CDBF462-005E-46B8-A0CA-12C066E78C4DQ35609965-6890FC18-6BC5-460F-BA6D-2A5CECE1A18EQ36518633-46102607-B296-423A-8972-C5D0CE6F52E5Q36926278-F16010F5-5369-4E02-9B1B-4AFBE92D6CB0Q37476043-9B762363-DACD-4023-B5F5-2403DD61A49BQ37650625-61037CC6-4BD1-47DD-8F94-182867AD33F6Q38928611-B7817B6F-2399-4BDC-B746-D0AF3654E31EQ39027000-CF3FDBAB-E442-4155-BB7E-3302E4628481Q39359077-6E89705B-C066-4874-A1C4-69EB8367F154Q39706486-EF24B462-E107-483B-A74D-ABD1B9F71F4CQ41783158-1E5BFE51-66AD-44A5-ACB7-FA8E271C31C1Q43084872-1DEBB1BA-67A0-48D3-8BE6-736CEF163F5E
P2860
Immunolocalization and messenger RNA expression of bone morphogenetic protein-6 in human benign and malignant prostatic tissue
description
1997 nî lūn-bûn
@nan
1997 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Immunolocalization and messeng ...... and malignant prostatic tissue
@ast
Immunolocalization and messeng ...... and malignant prostatic tissue
@en
Immunolocalization and messeng ...... and malignant prostatic tissue
@nl
type
label
Immunolocalization and messeng ...... and malignant prostatic tissue
@ast
Immunolocalization and messeng ...... and malignant prostatic tissue
@en
Immunolocalization and messeng ...... and malignant prostatic tissue
@nl
prefLabel
Immunolocalization and messeng ...... and malignant prostatic tissue
@ast
Immunolocalization and messeng ...... and malignant prostatic tissue
@en
Immunolocalization and messeng ...... and malignant prostatic tissue
@nl
P2093
P1433
P1476
Immunolocalization and messeng ...... and malignant prostatic tissue
@en
P2093
P304
P407
P577
1997-10-01T00:00:00Z